1 Product identity
Ingredient risk
Contains restricted ingredients
Joint
BrandNikken Wellness Kenzen→Other Combinations Softgel Capsule 19 ingredients 1 banned DSLD #307076Net contents: 90 Softgel(s)
Target: Adults and Children 4 years and above
DSLD entry: 2024-03-22
2 Ingredients (19)
IngredientGroupSafety
CaloriesCalories—
Calories from FatCalories—
Total FatFat (unspecified)—
High Potency CM ComplexBlend—
Cetyl OleateCetyl oleate—
Cetyl MyristateCetyl myristate—
Other Cetyl EstersCetylated Fatty Acids (mixed)—
Cetyl EsterCetyl Esters—
Extra Virgin Olive OilOlive Oil—
BeeswaxBeeswax—
GelatinGelatin—
GlycerinGlycerol—
WaterWater—
ChlorophyllChlorophyll—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⛔ Contains an ingredient banned in ≥1 country
Titanium Dioxide 🇫🇷 🇪🇺 — France banned TiO₂ in food from January 2020, first EU country.
3 Safety cross-reference
Cetyl Myristoleate — Conditionally Safe
⚠ Limited human data
⚠ GI effects
Glucosamine — Limited Evidence
⚠ Shellfish allergy
⚠ May affect glucose
Methylsulfonylmethane — Generally Safe
⚠ GI effects
⚠ Headache
Boswellia — Generally Safe
⚠ GI discomfort
⚠ May enhance anticoagulants
Titanium Dioxide — Banned in ≥1 country
⚠ EFSA: can no longer be considered safe as food additive (2021)
⚠ Genotoxicity concern (nanoparticles)
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID307076
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2024-03-22
6 More from Nikken Wellness Kenzen
Lactoferrin 2.07 Cite this page
Vancouver
Pkhakadze G. Joint — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Oct 18]. Available from: https://supplement.ge/products/joint-307076/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG